Acquisition Expansion Praxis has a history of strategic acquisitions, most recently acquiring Acipak in 2025 and expanding capabilities with Advanced Concept Innovations. This signals potential cross-sell opportunities to integrate packaging solutions across newly acquired entities and leverage combined capabilities for broader contract packaging needs.

Regulatory Compliance Power With FDA, DEA, cGMP compliance and DSCSA serialization and aggregation services, Praxis positions itself as a trusted partner for customers facing strict regulatory requirements, creating a sales angle around compliant and traceable packaging for serialized products and controlled substances.

ColdChain & DEA Capabilities Facilities exceed 650,000 sq ft with cold-chain management and the ability to package DEA schedule III-V drugs, opening opportunities with pharma brands requiring temperature-controlled packaging solutions and secure handling of regulated products.

Turnkey Packaging Strength End-to-end primary and secondary packaging services including labeling, cartoning, blistering, and stretch packaging, plus fast DSCSA turnaround, enable Praxis to compete for large, integrated packaging projects and shorten time-to-market for clients.

Growth & Market Position A mid-sized yet scalable partner with a multi-decade track record, ongoing investments (TF2 Blister Pack System, leadership additions), and active market expansion (Michigan growth, DCAT Week presence) suggests strong upsell potential with mid-market pharmaceutical manufacturers seeking reliable packaging partners.